You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Hepatitis C: Hepatitis B Vaccination

Percentage of patients aged 18 years and older with a diagnosis of hepatitis C who have received at least one injection of hepatitis B vaccine, or who have documented immunity to hepatitis B

Date Reviewed: July 26, 2014

Measure Info

NQF 0400CMS 184NQF Endorsement Removed
Measure Type: 
Measure Steward: 
Physician Consortium for Performance Improvement
Clinical Topic Area: 
Hepatitis C

Care Setting: 
Data Source: 
Electronic Health Data
Electronic Health Records

ACP does not support PQRS 184: “Hepatitis C: Hepatitis B Vaccination” because the basis for the measure in the relevant ACIP guideline is ambiguous. While the guideline states that concurrent HBV and HCV infections may increase the chance of chronic liver disease, it also concludes that those with chronic liver disease are not at increased risk of HBV infection in the absence of plausible percutaneous or mucosal exposure. In the absence of a clear rationale, the measure does not contribute to the provision of high quality care.